European Pharmaceutical Contractor |
 |
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EPC provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in the current issue of EPC. |
 |
| |
|
|
|
|
|
Advanced eClinical technology can help the pharmaceutical industry to improve productivity and reduce costs in
order to meet the demands of a difficult marketplace environment, explains Wade Wirta at Perceptive Informatics |
|
|
| There’s no competitive advantage in submissions management, so why be dragged down
by the process? Adam Sherlock of ISI says it is time to let someone else do it |
|
|
| Margaret Osborn of Synergy Marketing Group, Inc, applies the power of electronic marketing
and demonstrates the ways in which it drives awareness, demand and leads |
|
|
| Jane Nathan at PharmaEd emphasises the importance of appropriate medical training for clinical teams |
|
|
|
|
| Colin Bell at Brabners Chaffe Street discusses the need for effective IP strategies for pharmaceutical innovations |
|
|
| Claire Madden-Smith at Molecular Profiles examines the most effective lifecycle
management strategies and the role of intellectual property |
|
|
| Philip Payne at RSSL Pharma believes that for any company working in the pharmaceutical industry
complying with the regulations and guidelines issued by any of the regulatory bodies represents
both a commitment and a challenge |
|
|
|
|
| Joop van Gerven and Justin Hay of CHDR discuss how carefully chosen biomarkers can easily be incorporated
into early phase drug studies, providing guidance for important decisions concerning a drug’s future |
|
|
| Lisa L Mathis at the Paediatric and Maternal Health Staff Office of New Drugs, FDA,
argues the case for better paediatric drug testing |
|
|
| Graham Wylie of the MRN discusses the use of clinical trial support organisations (CTSOs)
for home-based drug administration in clinical trials with parenteral therapies |
|
|
|
Janet Edwards of AstraZeneca explores how partnership and innovation works for global clinical development |
|
|
|
| Peter Gaskin at Aptuit Consulting assesses the failure of neuroprotectives in the clinic and questions
whether the lessons can be applied to the design of animal models for other CNS indications |
|
|
| Natalie Appels and Ilona Verbaan-Giebelen of NOTOX BV propose
in vitro testing alternatives for designing a better preclinical and
clinical package, reducing animal use and drug development costs |
|
|
| In liquid handling quality assurance, location is vital
for improving quality in drug discovery and development
processes, claims George Rodrigues at ARTEL |
|
|
|
| Is electronic data capture standardisation the next evolution in clinical trial productivity?
Simon Hawken of eResearchTechnology, Inc explores this faster and cheaper method for data collection |
|
|
|
|
| Intelligent automation and control solutions can optimise manufacturing performance
and safeguard product quality, claims Walfried Laibacher of Honeywell Building Solutions |
|
|
|
Don Riach at Marken outlines the challenges of temperature controlled
pharmaceutical logistics and the role of the specialist courier company |
|
|
|
Hermann Schulz of INTERLAB GmbH provides an update on the logistics
of shipping biological samples across borders |
|
|
|
| James Conklin of ICON Medical Imaging charts the evolution
of commercial imaging core laboratory technology systems |
|
|
|
|
|
